Proteomics

Dataset Information

Spatial proteomics of selinexor, MK-2206 and combination response in AML cells


ABSTRACT: In order to characterize the dynamics of proteins between different cellular compartments in response to selinexor (XPO1 inhibitor), MK-2206 (Akt inhibitor) an the combination i AML cells, we treated MV4-11 and PL-21 cells for 6 hours with DMSO, 1 uM selinexor, 1 uM MK-2206 or the combination. Each condition was performed in 4 biological bio-reps.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Myeloblast, Leukemia Cell

DISEASE(S): Acute Leukemia

SUBMITTER: Kristina Bennet Emdal  

LAB HEAD: Jesper V. Olsen

PROVIDER: PXD033527 | Pride | 2022-08-07

REPOSITORIES: Pride

Similar Datasets